Actively Recruiting
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
Led by Boston University Charles River Campus · Updated on 2026-05-04
2
Participants Needed
3
Research Sites
160 weeks
Total Duration
On this page
Sponsors
B
Boston University Charles River Campus
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Persistent developmental stuttering affects more than three million people in the United States, and it can have profound adverse effects on quality of life. Despite its prevalence and negative impact, stuttering has resisted explanation and effective treatment, due in large part to a poor understanding of the neural processing impairments underlying the disorder. The overall goal of this study is to improve understanding of the brain mechanisms involved in speech motor planning and how these are disrupted in neurogenic speech disorders, like stuttering. The investigators will do this through an integrated combination of experiments that involve speech production, functional MRI, and non-invasive brain stimulation. The study is designed to test hypotheses regarding the brain processes involved in learning and initiating new speech sound sequences and how those processes compare in persons with persistent developmental stuttering and those with typical speech development. These processes will be studied in both adults and children. Additionally, these processes will be investigated in patients with neurodegenerative speech disorders (primary progressive aphasia) to further inform the investigators understanding of the neural mechanisms that support speech motor sequence learning. Together these experiments will result in an improved account of the brain mechanisms underlying speech production in fluent speakers and individuals who stutter, thereby paving the way for the development of new therapies and technologies for addressing this disorder.
CONDITIONS
Official Title
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy individuals with no history of neurological, speech, or hearing disorders (except stuttering in adults who stutter).
- Native speakers of American English with limited exposure to a second language.
- Adults must pass a pure-tone hearing screening at 25dB at 500, 1k, 2k, and 4kHz.
- Children must pass a hearing screening at 20dB at 500, 1k, 2k, and 4kHz.
- Participants who read orthographic stimuli must have normal or corrected-to-normal vision.
- Children will complete speech, language, hearing, and cognitive tests and be within normal ranges for their age except for stuttering in children who stutter.
- Persons who stutter will be evaluated by a speech-language pathologist to assess severity and rule out other disorders.
- Participants with primary progressive aphasia (PPA) must have a diagnosis from MGH-FTD, a Clinical Dementia Rating score of 1.0 or lower, and recent clinical assessment and brain scan.
- Children must be between 6 and 8 years old.
You will not qualify if you...
- Contraindications for tDCS or MRI procedures, including metallic implants in the head, electrically sensitive devices, history of seizures, significant scalp lesions, pregnancy, severe claustrophobia, or ferromagnetic materials in the body.
- Participants performing more than 2 standard deviations below norms on a nonword repetition pre-test are excluded.
- Children with neurological disorders other than stuttering or outside the 6 to 8 years age range are excluded.
- Participants with PPA taking medications expected to affect speech or language are excluded.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02129
Actively Recruiting
2
Boston University
Boston, Massachusetts, United States, 02215
Actively Recruiting
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
F
Frank H Guenther, PhD
CONTACT
B
Barbara Holland
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here